Drug details
Zelapar (selegiline hydrochloride)
type of Antiparkinson Agents, MAO Type B Inhibitors
Zelapar (selegiline hydrochloride) is an enzyme blocker (MAO inhibitor) that works by slowing the breakdown of certain natural substances in the brain (neurotransmitters such as dopamine, norepinephrine, and serotonin) used together with other medicines to treat symptoms of Parkinson's disease.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- vomiting,
- diarrhea,
- fever,
- lightheadedness,
- shortness of breath,
- confusion,
- severe headache,
- blurred vision,
- pounding in your neck or ears,
- fainting,
- agitation,
- overactive reflexes,
- anxiety,
- hallucinations,
- unusual thoughts or behavior,
- fast heart rate,
- loss of coordination,
- seizures
- severe chest pain,
- pounding heartbeats, and
- uncontrolled muscle movements,
- increased tremors,
- worsening side effects of your other medications,
The following drugs are related to Zelapar, either as a replacement or used together:
- Symmetrel (amantadine hydrochloride)
- Kynmobi (apomorphine hydrochloride sublingual film)
- Azilect (rasagiline)
- Cogentin (benztropine mesylate injection)
- Parlodel (bromocriptine mesylate)
- Comtan (entacapone)
- Eldepryl (selegiline hcl)
- Exelon (rivastigmine tartrate)
- Exelon Patch (rivastigmine transdermal system)
- Fluorodopa FDOPA (f18 injection)
- Inbrija (levodopa inhalation powder)
- Nourianz (istradefylline tablets)
- Mirapex (pramipexole)
- Mirapex ER (pramipexole dihydrochloride extended-release tablets)
- Ongentys (opicapone capsules)
- Permax (pergolide mesylate)
- Requip (ropinirole hcl)
- Requip XL (ropinirole extended release tablets)
- Tasmar (tolcapone)